BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9863007)

  • 1. Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.
    Kubo K; Matsuzaki Y; Kato A; Terai S; Okita K
    Int J Oncol; 1999 Jan; 14(1):41-6. PubMed ID: 9863007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in human choriocarcinoma cell lines by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone).
    Isaka K; Fujito A; Sagawa Y; Yudate T; Nishi H; Ito H; Takayama M
    Oncol Rep; 2002; 9(6):1299-305. PubMed ID: 12375038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
    Wang C; Tang C; Tang L
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines.
    Rahman MA; Dhar DK; Masunaga R; Yamanoi A; Kohno H; Nagasue N
    Cancer Res; 2000 Apr; 60(8):2085-9. PubMed ID: 10786664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells.
    Date M; Fukuchi K; Namiki Y; Okumura A; Morita S; Takahashi H; Ohura K
    Liver Int; 2004 Apr; 24(2):142-8. PubMed ID: 15078479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesnarinone exhibits antitumor effect against myeloid leukemia cells via apoptosis.
    Fujiwara H; Arima N; Otsubo H; Matsushita K; Hidaka S; Arimura K; Kukita T; Yamaguchi K; Tanaka H
    Exp Hematol; 1997 Oct; 25(11):1180-6. PubMed ID: 9328455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ
    Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of anticancer effects of radiation and conventional anticancer agents by a quinolinone derivative, vesnarinone: studies on human gastric cancer tissue xenografts in nude mice.
    Kawai K; Konishi Y; Izumi K; Sato M; Adachi M; Hozumi M
    Anticancer Res; 1998; 18(1A):405-12. PubMed ID: 9568110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
    Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
    Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
    Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma.
    Wada A; Fukui K; Sawai Y; Imanaka K; Kiso S; Tamura S; Shimomura I; Hayashi N
    J Hepatol; 2006 Jan; 44(1):142-50. PubMed ID: 16298452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cycloprodigiosin hydrochloride, a new H(+)/Cl(-) symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice.
    Yamamoto C; Takemoto H; Kuno K; Yamamoto D; Tsubura A; Kamata K; Hirata H; Yamamoto A; Kano H; Seki T; Inoue K
    Hepatology; 1999 Oct; 30(4):894-902. PubMed ID: 10498640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II.
    Lund P; Schubert D; Niketeghad F; Schirmacher P
    Cancer Lett; 2004 Mar; 206(1):85-96. PubMed ID: 15019164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analogue TT-232.
    Diaconu CC; Szathmári M; Kéri G; Venetianer A
    Br J Cancer; 1999 Jun; 80(8):1197-203. PubMed ID: 10376972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
    Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ
    Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical application of vitamin K for hepatocellular carcinoma].
    Mizuta T; Ozaki I
    Clin Calcium; 2007 Nov; 17(11):1693-9. PubMed ID: 17982189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo.
    Zhang T; Wang SS; Hong L; Wang XL; Qi QH
    J Exp Clin Cancer Res; 2003 Mar; 22(1):61-8. PubMed ID: 12725324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
    Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    Harada K; Supriatno ; Yoshida H; Sato M
    Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway.
    Zhang H; Ozaki I; Mizuta T; Matsuhashi S; Yoshimura T; Hisatomi A; Tadano J; Sakai T; Yamamoto K
    Cancer; 2002 Aug; 95(4):896-906. PubMed ID: 12209735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.